Amgen recalls EPO drug batches
This article was originally published in Scrip
Executive Summary
Amgen and the US FDA have notified healthcare professionals that certain lots of the anaemia treatments Epogen and Procrit (epoetin alfa), sold by Johnson & Johnson's Ortho Biotech unit, are being voluntarily recalled as a precaution because they may contain "extremely thin" bits of glass that may have flaked off from vials into the product.